Lymphoma, Large B-Cell, Diffuse MeSH Descriptor Data 2023

MeSH Heading: Lymphoma, Large B-Cell, Diffuse
Tree Number(s): C04.557.386.480.150.585; C15.604.515.569.480.150.585; C20.683.515.761.480.150.585
Unique ID: D016403
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D016403
Scope Note: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
Entry Term(s): Diffuse Large B-Cell Lymphoma; Diffuse Large-Cell Lymphoma; Diffuse, Large B-Cell, Lymphoma; Histiocytic Lymphoma; Histiocytic Lymphoma, Diffuse; Large Lymphoid Lymphoma, Diffuse; Large-Cell Lymphoma, Diffuse; Lymphoma, Diffuse Large-Cell; Lymphoma, Histiocytic; Lymphoma, Histiocytic, Diffuse; Lymphoma, Large Cell, Diffuse; Lymphoma, Large Lymphoid, Diffuse; Lymphoma, Large-Cell, Diffuse
NLM Classification #: WH 525
Public MeSH Note: 2008; see LYMPHOMA, LARGE-CELL, DIFFUSE 1991-2007; for LYMPHOMA, LARGE-CELL see LYMPHOMA, LARGE-CELL 1991-2007, see LYMPHOMA, HISTIOCYTIC
History Note: 2008 (1991)
Date Established: 1991/01/01
Date of Entry: 1990/06/01
Revision Date: 2020/01/16

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

chemistry (CH)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

ultrastructure (UL)

urine (UR)

veterinary (VE)

virology (VI)

Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
  - Lymphoma [C04.557.386]
    - Lymphoma, Non-Hodgkin [C04.557.386.480]
      - Lymphoma, B-Cell [C04.557.386.480.150]
        
        Burkitt Lymphoma [C04.557.386.480.150.165]
        
        Lymphoma, AIDS-Related [C04.557.386.480.150.450]
        
        Lymphoma, B-Cell, Marginal Zone [C04.557.386.480.150.570]
        
        Lymphoma, Large B-Cell, Diffuse [C04.557.386.480.150.585]
        
        Plasmablastic Lymphoma [C04.557.386.480.150.585.500]
        
        Lymphoma, Primary Effusion [C04.557.386.480.150.592]
        
        Lymphomatoid Granulomatosis [C04.557.386.480.150.600]

Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
  - Lymphoproliferative Disorders [C15.604.515]
    - Lymphoma [C15.604.515.569]
      - Lymphoma, Non-Hodgkin [C15.604.515.569.480]
        
        Lymphoma, B-Cell [C15.604.515.569.480.150]
        
        Burkitt Lymphoma [C15.604.515.569.480.150.165]
        
        Lymphoma, AIDS-Related [C15.604.515.569.480.150.450]
        
        Lymphoma, B-Cell, Marginal Zone [C15.604.515.569.480.150.570]
        
        Lymphoma, Large B-Cell, Diffuse [C15.604.515.569.480.150.585]
        
        Plasmablastic Lymphoma [C15.604.515.569.480.150.585.500]
        
        Lymphoma, Primary Effusion [C15.604.515.569.480.150.592]
        
        Lymphomatoid Granulomatosis [C15.604.515.569.480.150.600]

Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
  - Lymphoproliferative Disorders [C20.683.515]
    - Lymphoma [C20.683.515.761]
      - Lymphoma, Non-Hodgkin [C20.683.515.761.480]
        
        Lymphoma, B-Cell [C20.683.515.761.480.150]
        
        Burkitt Lymphoma [C20.683.515.761.480.150.165]
        
        Lymphoma, AIDS-Related [C20.683.515.761.480.150.450]
        
        Lymphoma, B-Cell, Marginal Zone [C20.683.515.761.480.150.570]
        
        Lymphoma, Large B-Cell, Diffuse [C20.683.515.761.480.150.585]
        
        Plasmablastic Lymphoma [C20.683.515.761.480.150.585.500]
        
        Lymphoma, Primary Effusion [C20.683.515.761.480.150.592]
        
        Lymphomatoid Granulomatosis [C20.683.515.761.480.150.600]

Lymphoma, Large B-Cell, Diffuse Preferred

Concept UI: M0025086
Scope Note: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
Terms: Lymphoma, Large B-Cell, Diffuse Preferred Term
Term UI T688324
Date12/21/2006
LexicalTag NON
ThesaurusID NLM (2008); Lymphoma, Histiocytic
Term UI T024499
Date05/13/1990
LexicalTag NON
ThesaurusID NLM (1991); Lymphoma, Large Lymphoid, Diffuse
Term UI T049044
Date05/13/1990
LexicalTag NON
ThesaurusID NLM (1991); Lymphoma, Histiocytic, Diffuse
Term UI T049042
Date05/13/1990
LexicalTag NON
ThesaurusID NLM (1991); Lymphoma, Large Cell, Diffuse
Term UI T049050
Date05/14/1990
LexicalTag NON
ThesaurusID NLM (1991); Lymphoma, Diffuse Large-Cell
Term UI T049049
Date05/25/1990
LexicalTag NON
ThesaurusID NLM (1991); Diffuse Large-Cell Lymphoma
Term UI T049047
Date05/25/1990
LexicalTag NON
ThesaurusID NLM (1991); Diffuse, Large B-Cell, Lymphoma
Term UI T688325
Date12/21/2006
LexicalTag NON
ThesaurusID NLM (2008); Histiocytic Lymphoma
Term UI T024498
Date05/13/1990
LexicalTag NON
ThesaurusID NLM (1991); Histiocytic Lymphoma, Diffuse
Term UI T049041
Date05/13/1990
LexicalTag NON
ThesaurusID NLM (1991); Large Lymphoid Lymphoma, Diffuse
Term UI T049043
Date05/14/1990
LexicalTag NON
ThesaurusID NLM (1991); Large-Cell Lymphoma, Diffuse
Term UI T049048
Date05/14/1990
LexicalTag NON
ThesaurusID NLM (1991); Diffuse Large B-Cell Lymphoma
Term UI T000999268
Date11/22/2019
LexicalTag NON
ThesaurusID NLM (2021); Lymphoma, Large-Cell, Diffuse
Term UI T049051
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1991)

page delivered in 0.147s